Try GOLD - Free
XED sets the syllabus for GIFT City listings
Business Standard
|September 08, 2025
XED, a global education technology (edtech) firm focused on executive programmes with leading universities, is preparing to raise $12 million through an initial public offering (IPO) at the International Financial Services Centre (IFSC) in Gujarat International Finance Tec-City (GIFT City).
This will be the first IPO at the IFSC and could serve as a template for other companies considering the tax-friendly jurisdiction.
XED Founder and Chief Executive Officer John Kallelil said GIFT City was chosen for its strategic value, given the firm's presence in India, the United Arab Emirates, Saudi Arabia, Singapore, and the US.
This story is from the September 08, 2025 edition of Business Standard.
Subscribe to Magzter GOLD to access thousands of curated premium stories, and 10,000+ magazines and newspapers.
Already a subscriber? Sign In
MORE STORIES FROM Business Standard
Business Standard
China’s PVC rethink to help India pipe makers
Supply likely to tighten after S-PVC rebate withdrawal
2 mins
January 13, 2026
Business Standard
Responsible growth
India must ensure data centres are sustainable
2 mins
January 13, 2026
Business Standard
India’s GenZ is full of creativity: PM
Prime Minister Narendra Modi on Monday said India's GenZ is full of creativity and with innovative ideas, energy and purpose, the country’s youth is at the forefront of nation-building.
1 min
January 13, 2026
Business Standard
Iran wants to negotiate after threats to attack, says Trump
At least 572 killed in protests; Tehran says situation ‘under full control’
2 mins
January 13, 2026
Business Standard
Insurers knock on Irdai door for clarity on director overlap ban
CLAUSE THREATENS BOARD STRUCTURES AT BANK-BACKED FIRMS SAYS INDUSTRY
2 mins
January 13, 2026
Business Standard
Delhi HC allows Zydus to sell generic version of cancer drug
Citing public interest, the Delhi High Court has cleared the way for Zydus Life-sciences to proceed with the sale of its version of the cancer drug nivolumab in India.
1 min
January 13, 2026
Business Standard
India faces 2nd highest economic burden due to diabetes: Study
India faces the second highest economic burden due to diabetes of $11.4 trillion — the United States bears the highest costs at $16.5 trillion, and China the third at $11 trillion, a new study has estimated.
2 mins
January 13, 2026
Business Standard
Nissan strengthens India leadership, appoints Thierry Sabbagh prez
Nissan has announced aseries of senior management changes in its Africa, Middle East, India, Europe and Oceania (AMIEO) region.
1 mins
January 13, 2026
Business Standard
THE MANAGEMENT REVOLUTION — BRIDGING THE GAP BETWEEN THEORY AND TOMORROW
The landscape of higher learning has evolved most dramatically within management studies over the last several decades.
2 mins
January 13, 2026
Business Standard
Determined to cross finish line on trade deal: US envoy Gor
Says both nations remain ‘actively’ engaged, next call scheduled today
1 mins
January 13, 2026
Listen
Translate
Change font size